Nevro Corp. (NVRO): Price and Financial Metrics

Nevro Corp. (NVRO): $43.32

0.13 (+0.30%)

POWR Rating

Component Grades














  • NVRO scores best on the Value dimension, with a Value rank ahead of 58.66% of US stocks.
  • NVRO's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • NVRO's current lowest rank is in the Sentiment metric (where it is better than 6.82% of US stocks).

NVRO Stock Summary

  • NVRO's price/sales ratio is 6.54; that's higher than the P/S ratio of 78.08% of US stocks.
  • With a year-over-year growth in debt of -49.05%, Nevro Corp's debt growth rate surpasses only 7.75% of about US stocks.
  • In terms of volatility of its share price, NVRO is more volatile than 84.53% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Nevro Corp are EKSO, STIM, ATEC, KRMD, and TAOP.
  • NVRO's SEC filings can be seen here. And to visit Nevro Corp's official web site, go to

NVRO Valuation Summary

  • In comparison to the median Healthcare stock, NVRO's price/sales ratio is 8.37% lower, now standing at 10.4.
  • Over the past 83 months, NVRO's EV/EBIT ratio has gone down 79.7.
  • Over the past 83 months, NVRO's price/sales ratio has gone down 11.2.

Below are key valuation metrics over time for NVRO.

Stock Date P/S P/B P/E EV/EBIT
NVRO 2021-08-31 10.4 11.9 -62.3 -101.4
NVRO 2021-08-30 10.1 11.6 -60.7 -98.8
NVRO 2021-08-27 10.1 11.6 -60.8 -99.0
NVRO 2021-08-26 9.8 11.2 -58.6 -95.4
NVRO 2021-08-25 9.7 11.1 -58.4 -95.1
NVRO 2021-08-24 9.9 11.3 -59.1 -96.2

NVRO Growth Metrics

    The 3 year cash and equivalents growth rate now stands at -16.82%.
  • Its 2 year cash and equivalents growth rate is now at 382.33%.
  • The year over year net income to common stockholders growth rate now stands at -3.83%.
NVRO's revenue has moved up $5,103,000 over the prior 34 months.

The table below shows NVRO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 386.905 -41.881 -131.36
2021-09-30 393.876 -14.863 -108.355
2021-06-30 409.131 11.835 -68.265
2021-03-31 363.191 -0.499 -87.738
2020-12-31 362.048 1.191 -83.065
2020-09-30 366.691 -24.143 -89.678

NVRO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVRO has a Quality Grade of C, ranking ahead of 65.95% of graded US stocks.
  • NVRO's asset turnover comes in at 0.556 -- ranking 79th of 186 Medical Equipment stocks.
  • CSII, KRMD, and BIOL are the stocks whose asset turnover ratios are most correlated with NVRO.

The table below shows NVRO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.556 0.700 -0.058
2021-03-31 0.469 0.693 -0.084
2020-12-31 0.521 0.690 -0.093
2020-09-30 0.596 0.690 -0.124
2020-06-30 0.673 0.689 -0.160
2020-03-31 0.867 0.697 -0.146

NVRO Stock Price Chart Interactive Chart >

Price chart for NVRO

NVRO Price/Volume Stats

Current price $43.32 52-week high $182.45
Prev. close $43.19 52-week low $41.74
Day low $43.00 Volume 371,426
Day high $43.97 Avg. volume 634,107
50-day MA $62.56 Dividend yield N/A
200-day MA $86.95 Market Cap 1.53B

Nevro Corp. (NVRO) Company Bio

Nevro Corporation develops and commercializes a neuromodulation platform for the treatment of chronic pain. The company was founded in 2006 and is founded in Menlo Park, California.

NVRO Latest News Stream

Event/Time News Detail
Loading, please wait...

NVRO Latest Social Stream

Loading social stream, please wait...

View Full NVRO Social Stream

Latest NVRO News From Around the Web

Below are the latest news stories about Nevro Corp that investors may wish to consider to help them evaluate NVRO as an investment opportunity.

Nevro Corp. 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Nevro Corp. in conjunction with their 2021 Q4 earnings call....

SA Transcripts on Seeking Alpha | February 24, 2022

Nevro Corp.'s (NVRO) CEO Keith Grossman On Q4 2021 Results - Earnings Call Transcript

Nevro Corp. (NVRO) Q4 2021 Earnings Conference Call February 23, 2022 4:30 P.M. ET Company Participants Julie Dewey - Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, Chief Executive Officer and President Rod MacLeod - Chief Financial Officer Conference Call Participants Chris Pasquale - Guggenheim Adam Maeder -...

SA Transcripts on Seeking Alpha | February 24, 2022

Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates

Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q4 due to soft geographical performances.

Yahoo | February 24, 2022

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 0% and 0.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance

Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the first quarter and full-year of 2022.

Yahoo | February 23, 2022

Read More 'NVRO' Stories Here

NVRO Price Returns

1-mo -35.01%
3-mo -40.61%
6-mo -49.86%
1-year -71.07%
3-year -26.64%
5-year -41.33%
YTD -46.56%
2021 -53.17%
2020 47.27%
2019 202.24%
2018 -43.67%
2017 -4.98%

Continue Researching NVRO

Here are a few links from around the web to help you further your research on Nevro Corp's stock as an investment opportunity:

Nevro Corp (NVRO) Stock Price | Nasdaq
Nevro Corp (NVRO) Stock Quote, History and News - Yahoo Finance
Nevro Corp (NVRO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6697 seconds.